1. Home
  2. BIO vs MIR Comparison

BIO vs MIR Comparison

Compare BIO & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$278.96

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Logo Mirion Technologies Inc.

MIR

Mirion Technologies Inc.

HOLD

Current Price

$21.56

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
MIR
Founded
1952
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Machinery/Components
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIO
MIR
Price
$278.96
$21.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$358.50
$28.38
AVG Volume (30 Days)
289.2K
3.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.31
$23.84
Revenue Next Year
$3.10
$7.59
P/E Ratio
$9.72
$195.00
Revenue Growth
N/A
N/A
52 Week Low
$211.43
$12.00
52 Week High
$343.12
$30.28

Technical Indicators

Market Signals
Indicator
BIO
MIR
Relative Strength Index (RSI) 45.27 40.75
Support Level $266.71 $19.40
Resistance Level $290.01 $22.53
Average True Range (ATR) 9.32 1.03
MACD 0.34 -0.02
Stochastic Oscillator 57.28 27.89

Price Performance

Historical Comparison
BIO
MIR

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

Share on Social Networks: